Doubles Game: Src-Stat3 versus p53-PTEN in Cellular Migration and Invasion

REFERENCES

• Abdulghani, J., L. Gu, A. Dagvadorj, J. Lutz, B. Leiby, G. Bonuccelli, M. P. Lisanti, T. Zellweger, K. Alanen, T. Mirtti, T. Visakorpi, L. Bubendorf, and M. T. Nevalainen. 2008. Stat3 promotes metastatic progression of prostate cancer. Am. J. Pathol. 172:1717–1728.
   PubMed Web of Science ®Google Scholar
• Artym, V. V., Y. Zhang, F. Seillier-Moiseiwitsch, K. M. Yamada, and S. C. Mueller. 2006. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 66:3034–3043.
   PubMed Web of Science ®Google Scholar
• Aylon, Y., and M. Oren. 2007. Living with p53, dying of p53. Cell 130:597–600.
   PubMed Web of Science ®Google Scholar
• Bowman, T., M. A. Broome, D. Sinibaldi, W. Wharton, W. J. Pledger, J. M. Sedivy, R. Irby, T. Yeatman, S. A. Courtneidge, and R. Jove. 2001. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. U. S. A. 98:7319–7324.
   PubMed Web of Science ®Google Scholar
• Brisbin, S., J. Liu, J. Boudreau, J. Peng, M. Evangelista, and I. Chin-Sang. 2009. A role for C. elegans Eph RTK signaling in PTEN regulation. Dev. Cell 17:459–469.
   PubMedGoogle Scholar
• Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18:2553–2558.
   PubMed Web of Science ®Google Scholar
• Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. 1999. Stat3 as an oncogene. Cell 98:295–303.
   PubMed Web of Science ®Google Scholar
• Buccione, R., G. Caldieri, and I. Ayala. 2009. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 28:137–149.
   PubMed Web of Science ®Google Scholar
• Buccione, R., J. D. Orth, and M. A. McNiven. 2004. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 5:647–657.
   PubMed Web of Science ®Google Scholar
• Campisi, J. 2005. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120:513–522.
   PubMed Web of Science ®Google Scholar
• Chalhoub, N., and S. J. Baker. 2009. PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol. 4:127–150.
   PubMed Web of Science ®Google Scholar
• de la Iglesia, N., G. Konopka, S. V. Puram, J. A. Chan, R. M. Bachoo, M. J. You, D. E. Levy, R. A. DePinho, and A. Bonni. 2008. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev. 22:449–462.
   PubMed Web of Science ®Google Scholar
• de Stanchina, E., E. Querido, M. Narita, R. V. Davuluri, P. P. Pandolfi, G. Ferbeyre, and S. W. Lowe. 2004. PML is a direct p53 target that modulates p53 effector functions. Mol. Cell 13:523–535.
   PubMed Web of Science ®Google Scholar
• Devarajan, E., and S. Huang. 2009. STAT3 as a central regulator of tumor metastases. Curr. Mol. Med. 9:626–633.
   PubMed Web of Science ®Google Scholar
• Dey, N., H. E. Crosswell, P. De, R. Parsons, Q. Peng, J. D. Su, and D. L. Durden. 2008. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res. 68:1862–1871.
   PubMed Web of Science ®Google Scholar
• Efeyan, A., and M. Serrano. 2007. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6:1006–1010.
   PubMed Web of Science ®Google Scholar
• Eves, R., B. A. Webb, S. T. Zhou, and A. S. Mak. 2006. Caldesmon is an integral component of podosomes in smooth muscle cells. J. Cell Sci. 119:1691–1702.
   PubMed Web of Science ®Google Scholar
• Freeman, D. J., A. G. Li, G. Wei, H. H. Li, N. Kertesz, R. Lesche, A. D. Whale, H. Martinez-Diaz, N. Rozengurt, R. D. Cardiff, X. Liu, and H. Wu. 2003. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3:117–130.
   PubMed Web of Science ®Google Scholar
• Gadea, G., M. de Toledo, C. Anguille, and P. Roux. 2007. Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J. Cell Biol. 178:23–30.
   PubMed Web of Science ®Google Scholar
• Gadéa, G., L. Lapasset, C. Gauthier-Rouviere, and P. Roux. 2002. Regulation of Cdc42-mediated morphological effects: a novel function for p53. EMBO J. 21:2373–2382.
   PubMedGoogle Scholar
• Gao, S. P., and J. F. Bromberg. 2006. Touched and moved by STAT3. Sci. STKE 2006:pe30.
   PubMedGoogle Scholar
• Garcia, R., T. L. Bowman, G. Niu, H. Yu, S. Minton, C. A. Muro-Cacho, C. E. Cox, R. Falcone, R. Fairclough, S. Parsons, A. Laudano, A. Gazit, A. Levitzki, A. Kraker, and R. Jove. 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499–2513.
   PubMed Web of Science ®Google Scholar
• Geletu, M., C. Chaize, R. Arulanandam, A. Vultur, C. Kowolik, A. Anagnostopoulou, R. Jove, and L. Raptis. 2009. Stat3 activity is required for gap junctional permeability in normal rat liver epithelial cells. DNA Cell Biol. 28:319–327.
   PubMedGoogle Scholar
• Gimona, M., R. Buccione, S. A. Courtneidge, and S. Linder. 2008. Assembly and biological role of podosomes and invadopodia. Curr. Opin. Cell Biol. 20:235–241.
   PubMed Web of Science ®Google Scholar
• Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253:49–53.
   PubMed Web of Science ®Google Scholar
• Itoh, M., T. Murata, T. Suzuki, M. Shindoh, K. Nakajima, K. Imai, and K. Yoshida. 2006. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene 25:1195–1204.
   PubMed Web of Science ®Google Scholar
• Kruse, J. P., and W. Gu. 2009. Modes of p53 regulation. Cell 137:609–622.
   PubMed Web of Science ®Google Scholar
• Ku, T. K., D. C. Nguyen, M. Karaman, P. Gill, J. G. Hacia, and D. L. Crowe. 2007. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol. Cancer Res. 5:351–362.
   PubMedGoogle Scholar
• Leslie, N. R., H. Maccario, L. Spinelli, and L. Davidson. 2009. The significance of PTEN′s protein phosphatase activity. Adv. Enzyme Regul. 49:190–196.
   PubMedGoogle Scholar
• Leslie, N. R., X. Yang, C. P. Downes, and C. J. Weijer. 2005. The regulation of cell migration by PTEN. Biochem. Soc. Trans. 33:1507–1508.
   PubMedGoogle Scholar
• Leslie, N. R., X. Yang, C. P. Downes, and C. J. Weijer. 2007. PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr. Biol. 17:115–125.
   PubMed Web of Science ®Google Scholar
• Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323–331.
   PubMed Web of Science ®Google Scholar
• Lewis, B. C., D. S. Klimstra, N. D. Socci, S. Xu, J. A. Koutcher, and H. E. Varmus. 2005. The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma. Mol. Cell. Biol. 25:1228–1237.
   PubMedGoogle Scholar
• Li, A. G., L. G. Piluso, X. Cai, G. Wei, W. R. Sellers, and X. Liu. 2006. Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol. Cell 23:575–587.
   PubMed Web of Science ®Google Scholar
• Li, G. H., H. Wei, Z. T. Chen, S. Q. Lv, C. L. Yin, and D. L. Wang. 2009. STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells. J. Neurooncol. 91:165–174.
   PubMedGoogle Scholar
• Lin, J., X. Jin, K. Rothman, H. J. Lin, H. Tang, and W. Burke. 2002. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells. Cancer Res. 62:376–380.
   PubMed Web of Science ®Google Scholar
• Lin, J., H. Tang, X. Jin, G. Jia, and J. T. Hsieh. 2002. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Oncogene 21:3082–3088.
   PubMed Web of Science ®Google Scholar
• Linder, S. 2007. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 17:107–117.
   PubMed Web of Science ®Google Scholar
• Lund, T. C., C. Coleman, E. Horvath, B. M. Sefton, R. Jove, M. M. Medveczky, and P. G. Medveczky. 1999. The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activity. Cell. Signal. 11:789–796.
   PubMedGoogle Scholar
• Marx, J. 2006. Cell biology—podosomes and invadopodia help mobile cells step lively. Science 312:1868–1869.
   PubMed Web of Science ®Google Scholar
• Meek, D. W. 2009. Tumour suppression by p53: a role for the DNA damage response? Nat. Rev. Cancer 9:714–723.
   PubMed Web of Science ®Google Scholar
• Morton, J. P., D. S. Klimstra, M. E. Mongeau, and B. C. Lewis. 2008. Trp53 deletion stimulates the formation of metastatic pancreatic tumors. Am. J. Pathol. 172:1081–1087.
   PubMed Web of Science ®Google Scholar
• Moskovits, N., A. Kalinkovich, J. Bar, T. Lapidot, and M. Oren. 2006. p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res. 66:10671–10676.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, U. K., R. Eves, L. Jia, P. Mooney, and A. S. Mak. 2009. p53 suppresses Src-induced podosome and rosette formation and cellular invasiveness through the upregulation of caldesmon. Mol. Cell. Biol. 29:3088–3098.
   PubMedGoogle Scholar
• Muller, P. A., P. T. Caswell, B. Doyle, M. P. Iwanicki, E. H. Tan, S. Karim, N. Lukashchuk, D. A. Gillespie, R. L. Ludwig, P. Gosselin, A. Cromer, J. S. Brugge, O. J. Sansom, J. C. Norman, and K. H. Vousden. 2009. Mutant p53 drives invasion by promoting integrin recycling. Cell 139:1327–1341.
   PubMed Web of Science ®Google Scholar
• Myers, M. P., I. Pass, I. H. Batty, J. Van der Kaay, J. P. Stolarov, B. A. Hemmings, M. H. Wigler, C. P. Downes, and N. K. Tonks. 1998. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. U. S. A. 95:13513–13518.
   PubMed Web of Science ®Google Scholar
• Myers, M. P., J. P. Stolarov, C. Eng., J. Li, S. I. Wang, M. H. Wigler, R. Parsons, and N. K. Tonks. 1997. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. U. S. A. 94:9052–9057.
   PubMed Web of Science ®Google Scholar
• Ng, D. C., B. H. Lin, C. P. Lim, G. Huang, T. Zhang, V. Poli, and X. Cao. 2006. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J. Cell Biol. 172:245–257.
   PubMedGoogle Scholar
• Niu, G., T. Bowman, M. Huang, S. Shivers, D. Reintgen, A. Daud, A. Chang, A. Kraker, R. Jove, and H. Yu. 2002. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene 21:7001–7010.
   PubMed Web of Science ®Google Scholar
• Niu, G., K. L. Wright, Y. Ma, G. M. Wright, M. Huang, R. Irby, J. Briggs, J. Karras, W. D. Cress, D. Pardoll, R. Jove, J. Chen, and H. Yu. 2005. Role of Stat3 in regulating p53 expression and function. Mol. Cell. Biol. 25:7432–7440.
   PubMedGoogle Scholar
• Oikawa, T., T. Itoh, and T. Takenawa. 2008. Sequential signals toward podosome formation in NIH-src cells. J. Cell Biol. 182:157–169.
   PubMed Web of Science ®Google Scholar
• Paddison, P. J., M. Cleary, J. M. Silva, K. Chang, N. Sheth, R. Sachidanandam, and G. J. Hannon. 2004. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat. Methods 1:163–167.
   PubMed Web of Science ®Google Scholar
• Poincloux, R., C. Cougoule, T. Daubon, I. Maridonneau-Parini, and V. Le Cabec. 2007. Tyrosine-phosphorylated STAT5 accumulates on podosomes in Hck-transformed fibroblasts and chronic myeloid leukemia cells. J. Cell. Physiol. 213:212–220.
   PubMedGoogle Scholar
• Raftopoulou, M., S. Etienne-Manneville, A. Self, S. Nicholls, and A. Hall. 2004. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303:1179–1181.
   PubMed Web of Science ®Google Scholar
• Salmena, L., A. Carracedo, and P. P. Pandolfi. 2008. Tenets of PTEN tumor suppression. Cell 133:403–414.
   PubMed Web of Science ®Google Scholar
• Schreiner, S. J., A. P. Schiavone, and T. E. Smithgall. 2002. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. J. Biol. Chem. 277:45680–45687.
   PubMed Web of Science ®Google Scholar
• Sharpless, N. E., and R. A. DePinho. 2002. p53: good cop/bad cop. Cell 110:9–12.
   PubMed Web of Science ®Google Scholar
• Stambolic, V., D. MacPherson, D. Sas, Y. Lin, B. Snow, Y. Jang, S. Benchimol, and T. W. Mak. 2001. Regulation of PTEN transcription by p53. Mol. Cell 8:317–325.
   PubMed Web of Science ®Google Scholar
• Stiles, B. L. 2009. Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles. Int. J. Biochem. Cell Biol. 41:757–761.
   PubMed Web of Science ®Google Scholar
• Stylli, S. S., A. H. Kaye, and P. Lock. 2008. Invadopodia: at the cutting edge of tumour invasion. J. Clin. Neurosci. 15:725–737.
   PubMed Web of Science ®Google Scholar
• Sun, S., and B. M. Steinberg. 2002. PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J. Gen. Virol. 83:1651–1658.
   PubMedGoogle Scholar
• Vogelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408:307–310.
   PubMed Web of Science ®Google Scholar
• Wang, S. P., W. L. Wang, Y. L. Chang, C. T. Wu, Y. C. Chao, S. H. Kao, A. Yuan, C. W. Lin, S. C. Yang, W. K. Chan, K. C. Li, T. M. Hong, and P. C. Yang. 2009. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat. Cell Biol. 11:694–704.
   PubMed Web of Science ®Google Scholar
• Weaver, A. M. 2006. Invadopodia: specialized cell structures for cancer invasion. Clin. Exp. Metastasis 23:97–105.
   PubMed Web of Science ®Google Scholar
• Webb, B. A., L. Jia, R. Eves, and A. S. Mak. 2007. Dissecting the functional domain requirements of cortactin in invadopodia formation. Eur. J. Cell Biol. 86:189–206.
   PubMed Web of Science ®Google Scholar
• Xia, M., and H. Land. 2007. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat. Struct. Mol. Biol. 14:215–223.
   PubMed Web of Science ®Google Scholar
• Yeatman, T. J. 2004. A renaissance for SRC. Nat. Rev. Cancer 4:470–480.
   PubMed Web of Science ®Google Scholar
• Yoshio, T., T. Morita, Y. Kimura, M. Tsujii, N. Hayashi, and K. Sobue. 2007. Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation. FEBS Lett. 581:3777–3782.
   PubMedGoogle Scholar
• Yu, C. L., D. J. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz, and R. Jove. 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81–83.
   PubMed Web of Science ®Google Scholar
• Zbuk, K. M., and C. Eng. 2007. Cancer phenomics: RET and PTEN as illustrative models. Nat. Rev. Cancer 7:35–45.
   PubMed Web of Science ®Google Scholar
• Zhou, J., J. Wulfkuhle, H. Zhang, P. Gu, Y. Yang, J. Deng, J. B. Margolick, L. A. Liotta, E. Petricoin III, and Y. Zhang. 2007. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc. Natl. Acad. Sci. U. S. A. 104:16158–16163.
   PubMed Web of Science ®Google Scholar
• Zhou, S. T., B. A. Webb, R. Eves, and A. S. Mak. 2006. Effects of tyrosine phosphorylation of cortactin on podosome formation in A7r5 vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 290:C463–C471.
   PubMed Web of Science ®Google Scholar